Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer ...
Hosted on MSN11mon
Penumbra (PEN) Gains From Innovation, Mounting Costs AilCombined with Flash and Bolt 7, Penumbra expects its CAVT portfolio to drive both market share and market growth in Deep vein thrombosis, Pulmonary embolism and arterial. In terms of global ...
WBAL TV Baltimore on MSN3d
Mother shares story of survival after pulmonary embolism during childbirthA mom who takes nothing for granted is sharing her story after almost dying from a pulmonary embolism during childbirth.
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced new data that demonstrate patients with intermediate-risk pulmonary embolism (PE) treated with Penumbra's computer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback